Your browser doesn't support javascript.
loading
Assessment of Diagnosis Timing of Attention-Deficit/Hyperactivity Disorder in Working-Age Workers with Psychiatric Diseases Using Large Claims Data.
Ando, Mutsumi; Momo, Kenji; Hida, Noriko; Yamazaki, Taigi; Taki, Iori; Nagai, Tsutomu; Yoshio, Takashi; Kurosawa, Masahiro.
Afiliação
  • Ando M; Department of Clinical Pharmacy Division of Clinical Research and Development, School of Pharmacy, Showa University.
  • Momo K; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University.
  • Hida N; Department of Pharmacy, Showa University Karasuyama Hospital.
  • Yamazaki T; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University.
  • Taki I; Department of Clinical Pharmacy Division of Clinical Research and Development, School of Pharmacy, Showa University.
  • Nagai T; Department of Clinical Pharmacy Division of Clinical Research and Development, School of Pharmacy, Showa University.
  • Yoshio T; Department of Clinical Pharmacy Division of Clinical Research and Development, School of Pharmacy, Showa University.
  • Kurosawa M; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University.
Biol Pharm Bull ; 46(9): 1211-1216, 2023.
Article em En | MEDLINE | ID: mdl-37661400
ABSTRACT
Attention deficit/hyperactivity disorder (ADHD) is a common developmental disorder. This study aims to clarify the timing of diagnosis of ADHD in working-age workers with psychiatric comorbidities using large claims data in Japan. Based on a literature survey, we identified 10 typical comorbidities of ADHD. Among 3064162 participants with social insurance, 215060 working-age workers who were diagnosed with the 10 typical comorbidities of ADHD were included. Cohort 1 consisted of 96994 patients with the index date set as the earliest date of diagnosis of a comorbidity within the 12-month screening and 12-month observation periods. In cohort 2, 107436 patients were included, and the first date of diagnosis of each comorbidity was used as the index month. In cohort 1, 0.19% of the patients were diagnosed with ADHD after being diagnosed with a typical comorbidity. In cohort 2, 4 out of 4 patients with ADHD and obsessive-compulsive disorders were diagnosis ADHD after obsessive-compulsive disorders. Pervasive developmental disorders were the highest comorbidity of ADHD for 62 out of 566 (11.0%) patients. This is the first study to determine the proportion of ADHD with typical comorbidities in working-age workers in Japan. Our findings highlight the need for timely diagnosis of ADHD to improve patients' QOL.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade Tipo de estudo: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Biol Pharm Bull Assunto da revista: BIOQUIMICA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade Tipo de estudo: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Biol Pharm Bull Assunto da revista: BIOQUIMICA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article